Yes it is somewhat amusing - the downgrade occurred because the old strategy would have taken longer because of the switch to RC220, but there was no assessment of the value of the new strategy that required the switch to RC220. Now that the new strategy has now been assessed, it is really a vindication that the change to RC220 was worth the cost in time - we have a longer time frame for commercialisation, but with a much big market.
RAC
race oncology ltd
Add to My Watchlist
3.23%
!
$1.20

General Comments / Chat, page-11606
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
-0.040(3.23%) |
Mkt cap ! $208.4M |
Open | High | Low | Value | Volume |
$1.24 | $1.24 | $1.20 | $103.7K | 85.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 12091 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.22 | 9720 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 8091 | 1.200 |
2 | 19167 | 1.190 |
2 | 3887 | 1.180 |
1 | 5000 | 1.175 |
1 | 2598 | 1.155 |
Price($) | Vol. | No. |
---|---|---|
1.220 | 9720 | 1 |
1.230 | 1250 | 1 |
1.245 | 1355 | 1 |
1.250 | 4319 | 2 |
1.280 | 4060 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online